Skip to main content
. 2020 Mar 24;12:24. doi: 10.1186/s13098-020-00533-3

Table 2.

Baseline characteristics and medications of the participants

Control (n = 28) Omarigliptin (n = 56) p value
Age (years) 59.17 ± 7.85 59.00 ± 7.33 0.638
Male/(female) 21 (7) 40 (16) 0.8
Baseline medication
 Sitagliptin 19 40 0.802
 Linagliptin 9 16 0.802
 Sulfonylureas 5 11 1
 Metformin 7 14 1
 α-GI 4 6 0.7248
 ARB 9 18 1
 CCB 6 14 0.7913
 Statins 9 19 1
 Fibrates 5 11 1

Data were expressed as mean ± standard deviation

α-GI, α-glicosidase inhibitor; ARB, angiotensin II receptor blocker; CCB, calcium channel blocker